Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cosford

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
3-[3-Fluoro-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)phenyl]-4-methylpyridine: a highly potent and orally bioavailable metabotropic glutamate subtype 5 (mGlu5) receptor antagonistSteve F Poon, Brian W Eastman, Deborah F Chapman, et al.
Brain Research|August 12, 2008
Pharmacological characterization of (S)-(2)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine HCl (SIB-1508Y, Altinicline), a novel nicotinic acetylcholine receptor agonistTadimeti S Rao, Pamala B Adams, Lucia D Correa, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 18, 2010
The mGluR2 positive allosteric modulator BINA decreases cocaine self-administration and cue-induced cocaine-seeking and counteracts cocaine-induced enhancement of brain reward function in ratsXinchun Jin, Svetlana Semenova, Li Yang, et al.
The Journal of Biological Chemistry|September 28, 2011
Phosphomannose isomerase inhibitors improve N-glycosylation in selected phosphomannomutase-deficient fibroblastsVandana Sharma, Mie Ichikawa, Ping He, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 12, 2004
The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxietyChris S Busse, Jesse Brodkin, David Tattersall, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2017
Discovery of 5-((5-chloro-2-methoxyphenyl)sulfonamido)nicotinamide (SBI-425), a potent and orally bioavailable tissue-nonspecific alkaline phosphatase (TNAP) inhibitorAnthony B Pinkerton, Eduard Sergienko, Yalda Bravo, et al.
European Journal of Pharmacology|July 25, 2003
In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine)Jeffery J Anderson, Margaret J Bradbury, Darlene R Giracello, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 14, 2004
Metabotropic glutamate receptor mGlu5 is a mediator of appetite and energy balance in rats and miceMargaret J Bradbury, Una Campbell, Darlene Giracello, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2004
Pyrimidine methyl anilines: selective potentiators for the metabotropic glutamate 2 receptorEssa Hu, Peter C Chua, Lida Tehrani, et al.
The Biochemical Journal|February 21, 2019
Conservation of structure, function and inhibitor binding in UNC-51-like kinase 1 and 2 (ULK1/2)Apirat Chaikuad, Sebastian E Koschade, Alexandra Stolz, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
3-[3-Fluoro-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)phenyl]-4-methylpyridine: a highly potent and orally bioavailable metabotropic glutamate subtype 5 (mGlu5) receptor antagonistSteve F Poon, Brian W Eastman, Deborah F Chapman, et al.
Brain Research|August 12, 2008
Pharmacological characterization of (S)-(2)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine HCl (SIB-1508Y, Altinicline), a novel nicotinic acetylcholine receptor agonistTadimeti S Rao, Pamala B Adams, Lucia D Correa, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 18, 2010
The mGluR2 positive allosteric modulator BINA decreases cocaine self-administration and cue-induced cocaine-seeking and counteracts cocaine-induced enhancement of brain reward function in ratsXinchun Jin, Svetlana Semenova, Li Yang, et al.
The Journal of Biological Chemistry|September 28, 2011
Phosphomannose isomerase inhibitors improve N-glycosylation in selected phosphomannomutase-deficient fibroblastsVandana Sharma, Mie Ichikawa, Ping He, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 12, 2004
The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxietyChris S Busse, Jesse Brodkin, David Tattersall, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2017
Discovery of 5-((5-chloro-2-methoxyphenyl)sulfonamido)nicotinamide (SBI-425), a potent and orally bioavailable tissue-nonspecific alkaline phosphatase (TNAP) inhibitorAnthony B Pinkerton, Eduard Sergienko, Yalda Bravo, et al.
European Journal of Pharmacology|July 25, 2003
In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine)Jeffery J Anderson, Margaret J Bradbury, Darlene R Giracello, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 14, 2004
Metabotropic glutamate receptor mGlu5 is a mediator of appetite and energy balance in rats and miceMargaret J Bradbury, Una Campbell, Darlene Giracello, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2004
Pyrimidine methyl anilines: selective potentiators for the metabotropic glutamate 2 receptorEssa Hu, Peter C Chua, Lida Tehrani, et al.
The Biochemical Journal|February 21, 2019
Conservation of structure, function and inhibitor binding in UNC-51-like kinase 1 and 2 (ULK1/2)Apirat Chaikuad, Sebastian E Koschade, Alexandra Stolz, et al.
Pageof 11